FEN1 and neoplasm: These small molecule inhibitors affect Okazaki fragment maturation, genomic stability or DNA damage repair pathways (BER, HRR) by inhibiting FEN1, then killing tumor cells or increasing tumor sensitivity to chemotherapy drugs [16,59,78].